Tofidence Interactions
There are 427 drugs known to interact with Tofidence (tocilizumab), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 59 are major, 360 are moderate, and 8 are minor.
- View all 427 medications that may interact with Tofidence
- View Tofidence alcohol/food interactions (1)
- View Tofidence disease interactions (8)
Most frequently checked interactions
View interaction reports for Tofidence (tocilizumab) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Calquence (acalabrutinib)
Tofidence alcohol/food interactions
There is 1 alcohol/food interaction with Tofidence (tocilizumab).
Tofidence disease interactions
There are 8 disease interactions with Tofidence (tocilizumab) which include:
- infections
- tuberculosis
- demyelinating disorders
- gastrointestinal perforation
- lipid abnormalities
- liver dysfunction
- neutropenia/thrombocytopenia
- renal impairment
More about Tofidence (tocilizumab)
- Tofidence consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Plaquenil
Plaquenil is used to treat or prevent malaria and to treat the symptoms of rheumatoid arthritis ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Leflunomide
Leflunomide systemic is used for psoriatic arthritis, rheumatoid arthritis
Sulfasalazine
Sulfasalazine is used to treat ulcerative colitis, rheumatoid arthritis, and polyarticular-course ...
Hydroxychloroquine
Hydroxychloroquine is a quinoline drug used to treat or prevent malaria. It's also used to treat ...
Aleve
Aleve is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. Learn ...
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.